Product name:ALN-PCS01
Description:ALN-PCS01 is a systemically delivered RNAi therapeutic comprised of an optimized small interfering RNA (siRNA) encapsulated in a cationic liposomal nanoparticle formulation.Alnylam expects to file one investigational new drug (IND) application this year from its portfolio of systemically delivered RNAi therapeutic programs, which include ALN-PCS01 and ALN-VSP01, an RNAi therapeutic for the treatment of liver cancers and potentially other solid tumors.